Business Context and Reporting Period
Company: Alterity Therapeutics Ltd
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of January 2020
Principal Executive Office: Level 3, 460 Bourke Street, Melbourne, VIC 3000, Australia
This filing serves as a cover document incorporating "Appendix 4C – quarterly" by reference into Registration Statements on Form S-8 and Form F-3. The document itself does not contain the detailed quarterly financial data referenced in the appendix.
Key Financial Metrics
The provided text does not contain specific financial data. The following metrics are not disclosed in this filing excerpt:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt
- Liquidity
Note: The filing references an appendix containing quarterly information, but the content of that appendix is not included in the source text provided.
Material Changes
No material changes versus the prior comparable period are described in the provided text, as no comparative financial data is present.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, guidance, outlook, specific risks, contingencies, or unusual items. It is limited to administrative details regarding the incorporation of other documents by reference.
Investor Verification Checklist
- Verify the content of "Appendix 4C – quarterly" referenced in Item 99.1, as the actual financial results are not in this text.
- Review the Registration Statements on Form S-8 (File No. 333-228671) and Form F-3 (Files No. 333-220886 and 333-231417) for the incorporated information.
- Confirm the company's status as a Foreign Private Issuer filing under Form 20-F.